Metrovacesa Valuation
| MVC Stock | EUR 8.18 0.04 0.49% |
At this time, the firm appears to be undervalued. Metrovacesa SA secures a last-minute Real Value of €8.98 per share. The latest price of the firm is €8.18. Our model forecasts the value of Metrovacesa SA from analyzing the firm fundamentals such as Current Valuation of 1.04 B, profit margin of 0.05 %, and Return On Equity of 0.012 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Metrovacesa's price fluctuation is not too volatile at this time. Calculation of the real value of Metrovacesa SA is based on 3 months time horizon. Increasing Metrovacesa's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Metrovacesa is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Metrovacesa Stock. However, Metrovacesa's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.18 | Real 8.98 | Hype 8.14 | Naive 8.39 |
The real value of Metrovacesa Stock, also known as its intrinsic value, is the underlying worth of Metrovacesa SA Company, which is reflected in its stock price. It is based on Metrovacesa's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Metrovacesa's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Metrovacesa SA helps investors to forecast how Metrovacesa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Metrovacesa more accurately as focusing exclusively on Metrovacesa's fundamentals will not take into account other important factors: Metrovacesa Total Value Analysis
Metrovacesa SA is now forecasted to have takeover price of 1.04 B with market capitalization of 1.06 B, debt of 287.44 M, and cash on hands of 117.2 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Metrovacesa fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 1.04 B | 1.06 B | 287.44 M | 117.2 M |
Metrovacesa Investor Information
About 94.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Metrovacesa SA last dividend was issued on the 2nd of December 2022. Metrovacesa S.A. operates as a real estate development company in Spain. The company was incorporated in 1935 and is based in Madrid, Spain. METROVACESA operates under Real Estate - General classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1 people. To find out more about Metrovacesa SA contact Jorge Eguiguren at 34 913 18 37 00 or learn more at https://www.metrovacesa.com.Metrovacesa Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Metrovacesa has an asset utilization ratio of 18.39 percent. This indicates that the Company is making €0.18 for each dollar of assets. An increasing asset utilization means that Metrovacesa SA is more efficient with each dollar of assets it utilizes for everyday operations.Metrovacesa Ownership Allocation
Metrovacesa SA maintains a total of 151.45 Million outstanding shares. Metrovacesa SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 94.47 % of Metrovacesa SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Metrovacesa Profitability Analysis
The company reported the revenue of 510.74 M. Net Income was 23.73 M with profit before overhead, payroll, taxes, and interest of 104.78 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Metrovacesa's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Metrovacesa and how it compares across the competition.
About Metrovacesa Valuation
The stock valuation mechanism determines the current worth of Metrovacesa SA on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Metrovacesa SA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Metrovacesa SA based exclusively on its fundamental and basic technical indicators. By analyzing Metrovacesa's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Metrovacesa's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Metrovacesa. We calculate exposure to Metrovacesa's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Metrovacesa's related companies.Metrovacesa S.A. operates as a real estate development company in Spain. The company was incorporated in 1935 and is based in Madrid, Spain. METROVACESA operates under Real Estate - General classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1 people.
8 Steps to conduct Metrovacesa's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Metrovacesa's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Metrovacesa's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Metrovacesa's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Metrovacesa's revenue streams: Identify Metrovacesa's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Metrovacesa's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Metrovacesa's growth potential: Evaluate Metrovacesa's management, business model, and growth potential.
- Determine Metrovacesa's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Metrovacesa's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Metrovacesa Stock analysis
When running Metrovacesa's price analysis, check to measure Metrovacesa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metrovacesa is operating at the current time. Most of Metrovacesa's value examination focuses on studying past and present price action to predict the probability of Metrovacesa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metrovacesa's price. Additionally, you may evaluate how the addition of Metrovacesa to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |